David Lebwohl

David Lebwohl

Company: Intellia Therapeutics

Job title: CMO

Seminars:

Panel Discussion: Best Practices to Prevent Rejection and Achieve Long Lasting Responses 1:00 pm

• Review methods to prevent rejection and improve long term durability of allogeneic cells • Compare the different safety profiles of alternative cell types and the qualities that prevent rejection • Understand the best in class approaches for achieving increased depth of response and efficacyRead more

day: Track A - Day 2 - 3PM

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.